Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study
Abstract Background Although biologic agents have revolutionized the medical management of severe ulcerative colitis (UC), there is considerable controversy regarding adverse effects of vedolizumab on surgical outcomes. We evaluated 30-day postoperative morbidity in UC patients undergoing abdominal...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2020-03-01
|
| Rangatū: | BMC Surgery |
| Ngā marau: | |
| Urunga tuihono: | http://link.springer.com/article/10.1186/s12893-020-00698-8 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|